|
Volumn 3, Issue 6, 2006, Pages 749-753
|
US FDA perspective on regulatory issues affecting circulatory assist devices
|
Author keywords
Bridge to transplant; End stage heart failure; Mechanical circulatory assist; Regulatory procedures; Ventricular assist devices
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
THROMBIN INHIBITOR;
AORTA BALLOON;
ARTICLE;
ASSISTED CIRCULATION;
ASSISTIVE TECHNOLOGY DEVICE;
BRAIN HEMORRHAGE;
BRAIN INJURY;
CLINICAL EFFECTIVENESS;
CLINICAL TRIAL;
DEVICE INFECTION;
EMBOLISM;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE QUALITY;
HEART FAILURE;
HEART FUNCTION;
HEART TRANSPLANTATION;
HOMEOSTASIS;
HUMAN;
SAFETY;
SEPSIS;
THROMBOCYTE AGGREGATION;
THROMBOELASTOGRAPHY;
UNITED STATES;
VASCULAR ACCESS DEVICE;
DEVICE APPROVAL;
GUIDELINES;
HEART-ASSIST DEVICES;
HUMANS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 33845870402
PISSN: 17434440
EISSN: 17452422
Source Type: Journal
DOI: 10.1586/17434440.3.6.749 Document Type: Article |
Times cited : (5)
|
References (11)
|